India Expected to Ease COVID-19 Vaccine Export Restrictions

There is growing optimism that India could resume exports of COVID-19 vaccines as production expands at a rapid pace, putting the country on track to immunize its adult population in the coming months

“We had put a target of 1.85 billion doses for ourselves. That has been organized by the end of December and thereafter the government will be able to allow vaccine exports,” N.K. Arora, head of the national technical advisory group on immunization told VOA. “We will have several billion doses available next year.”

India, a vaccine powerhouse, was expected to be a major supplier of affordable COVID- 19 vaccines to developing countries.

However, after supplying 66 million doses to nearly 100 countries, New Delhi halted exports in April following a deadly second wave of the pandemic, slowing inoculation programs of countries from Africa to Indonesia.

There is no official comment on a timeline for resumption of exports, with officials stressing that for the time being, the focus is on India’s domestic rollout.

“First, all of our adults will have to be immunized, we have to take care of our own people,” Arora said.

The issue of vaccine supplies is expected to figure in the summit meeting of the Quad nations — the United States, Japan, India and Australia — Friday in Washington.

Public health experts say India will likely wait to restart exports until the country’s festive season ends in November to ensure it does not have to grapple with a third wave. Currently authorities are racing to administer at least one dose to all adults.

India has given one shot to roughly two thirds of its population but only 20% of its approximately 900 million adults have been fully inoculated.

In April, as a ferocious surge in infections took a heavy toll, the government had faced criticism for exporting vaccines when most of its own population was not inoculated.

India has been urged to resume exports as the country’s vaccination program gains momentum and the supply of vaccines increases.

The World Health Organization told a press briefing in Geneva Tuesday that it has been assured that supplies from India will restart this year. Officials said that discussions in New Delhi have emphasized the importance of ensuring that India is “part of the solution for Africa.”

African countries have struggled to inoculate their populations — only about 3% of the continent’s population is vaccinated.

“Given the successful ramp-up of domestic production and the diminishing intensity of its own outbreak, we hope that India will ease its restrictions,” a spokesman for the Gavi alliance, co-leading the global vaccine sharing platform COVAX, told VOA.

The Serum Institute of India, the world’s largest producer of the AstraZeneca vaccines, has said that exports could resume as India nears a level where sufficient stocks are available for its inoculation drive.

“In the next two months, we do expect slow easement of exports. But you have to also check with the government; ultimately it is their decision,” SII chief executive Adar Poonawalla said on Friday.

The institute was to be one of the major suppliers of affordable vaccines to COVAX, but the vaccine-sharing platform’s ability to get sufficient doses for low- and middle-income countries took a hit when India shut down exports.

“Countries with a low level of vaccination can breed variants and if the world does not cover those people there is an opportunity for mutants to rise and creep into other countries, making it harder control the pandemic,” K. Srinath Reddy, president of the Public Health Foundation of India, said.

Eyes will also be on the Quad summit next week to see how it makes headway on the vaccine initiative announced in March under which the four countries had decided to produce 1 billion doses in India by 2022 with financial backing from the United States and Japan.

“The summit will be a good opportunity to take stock and expedite that initiative. Some conversations have happened, let us see what progress is made,” an official in India’s Ministry of External Affairs, who did not want to be named, said.

Vaccines produced under the Quad initiative were meant for countries in the Indo-Pacific region. These and other developing countries have turned to China, which has supplied over a billion doses, while Western countries are seen to have lagged in their efforts to vaccinate developing countries.

However, hopes are rising that India will emerge as a major global supplier as new production facilities are set up and the basket of vaccines expands.

The SII for example is set to ramp up production to 200 million doses next month –nearly three times its output in April when India halted exports. Indian companies are also set to make millions of doses of both domestically developed vaccines and those developed overseas, such as the Johnson & Johnson vaccine, and Russia’s Sputnik V.

“It may look like a presumptuous statement, but we will immunize many countries next year, and these will be with affordable shots. There is no confusion in that. India is committed to it and I see no difficulty at all,” Arora said.

Source: Voice of America

World Leaders Return to UN with Focus on Pandemic, Climate

World leaders are returning to the United Nations in New York this week with a focus on boosting efforts to fight both climate change and the COVID-19 pandemic, which last year forced them to send video statements for the annual gathering.

As the coronavirus still rages amid an inequitable vaccine rollout, about a third of the 193 U.N. states are planning to again send videos, but presidents, prime ministers and foreign ministers for the remainder are due to travel to the United States.

The United States tried to dissuade leaders from coming to New York in a bid to stop the U.N. General Assembly from becoming a “super-spreader event,” although President Joe Biden will address the assembly in person, his first U.N. visit since taking office. A so-called U.N. honor system means that anyone entering the assembly hall effectively declares they are vaccinated, but they do not have to show proof.

This system will be broken when the first country speaks — Brazil. Brazilian President Jair Bolsonaro is a vaccine skeptic, who last week declared that he does not need the shot because he is already immune after being infected with COVID-19.

Should he change his mind, New York City has set up a van outside the United Nations for the week to supply free testing and free shots of the single-dose Johnson & Johnson vaccine.

U.N. Secretary-General Antonio Guterres told Reuters that the discussions around how many traveling diplomats might have been immunized illustrated “how dramatic the inequality is today in relation to vaccination.” He is pushing for a global plan to vaccinate 70% of the world by the first half of next year.

Out of 5.7 billion doses of coronavirus vaccines administered around the world, only 2% have been in Africa.

Biden will host a virtual meeting from Washington with leaders and chief executives on Wednesday that aims to boost the distribution of vaccines globally.

Demonstrating U.S. COVID-19 concerns about the U.N. gathering, Biden will be in New York only for about 24 hours, meeting with Guterres on Monday and making his first U.N. address on Tuesday, directly after Bolsonaro.

His U.N. envoy, Linda Thomas-Greenfield, said Biden would “speak to our top priorities: ending the COVID-19 pandemic; combating climate change … and defending human rights, democracy, and the international rules-based order.”

Due to the pandemic, U.N. delegations are restricted to much smaller numbers and most events on the sidelines will be virtual or a hybrid of virtual and in-person. Among other topics that ministers are expected to discuss during the week are Afghanistan and Iran.

But before the annual speeches begin, Guterres and British Prime Minister Boris Johnson will start the week with a summit on Monday to try and save a U.N. summit — that kicks off in Glasgow, Scotland, on Oct. 31 — from failure.

As scientists warn that global warming is dangerously close to spiraling out of control, the U.N. COP26 conference aims to wring much more ambitious climate action and the money to go with it from participants around the globe.

“It’s time to read the alarm bell,” Guterres told Reuters last week. “We are on the verge of the abyss.”

Source: Voice of America

Africa’s COVID-19 Cases Surpass 8.13 Million: Africa CDC

The number of confirmed COVID-19 cases in Africa reached 8,134,511 as of yesterday afternoon, the Africa Centres for Disease Control and Prevention (Africa CDC) said.

The Africa CDC, the specialised healthcare agency of the African Union, in its continental COVID-19 dashboard, indicated that the death toll from the pandemic across the continent stands at 206,202.

Some 7,454,718 patients across the continent have recovered from the disease so far.

South Africa, Morocco, Tunisia and Ethiopia are among the countries with the most cases in the continent, according to the agency.

In terms of the caseload, southern Africa is the most affected region, followed by the northern and eastern parts of the continent, while central Africa is the least affected region in the continent, according to the Africa CDC

Source: Nam News Network

WHO: Rich Countries’ Chokehold on COVID Vaccines Prolongs Pandemic in Africa

The World Health Organization is warning that COVID-19 vaccine export bans and hoarding by wealthy countries will prolong the pandemic in Africa, preventing recovery from the disease in the rest of the world.

While more than 60% of the U.S., European Union, and British populations have been vaccinated, only 2% of COVID vaccine shots have been given in Africa.

The COVAX facility has slashed its planned COVID-19 vaccine deliveries to Africa by 25% this year. WHO Africa regional director Matshidiso Moeti says the 470 million doses now expected to arrive by the end of December are enough to vaccinate just 17% of Africans on the continent.

“Export bans and vaccine hoarding still have a chokehold on the lifeline of vaccine supplies to Africa.… Even if all planned shipments via COVAX and the African Union arrive, Africa still needs almost 500 million more doses to reach the yearend goal. At this rate, the continent may only reach the 40% target by the end of March next year,” Moeti said.

The WHO reports more than 8 million cases of COVID-19 in Africa, including more than 200,000 deaths. Forty-four African countries have reported the alpha variant and 32 countries have reported the more virulent and contagious delta variant.

Moeti warns of further waves of infection and loss of life in this pandemic. Given the short supply of vaccines, she urges strict adherence to preventive measures, such as mask wearing and social distancing.

She reiterates WHO’s call for a halt to booster shots in wealthy nations, except for those with compromised immune systems and at risk of severe illness and death.

“I have said many times that it is in everyone’s interest to make sure the most at-risk groups in every country are protected. As it stands, the huge gaps in vaccine equity are not closing anywhere near fast enough. The quickest way to end this pandemic, is for countries with reserves to release their doses so that other countries can buy them,” she said.

Moeti said African countries with low vaccination rates are breeding grounds for vaccine-resistant variants. She warned this could end up sending the world back to square 1, with the pandemic continuing to ravage communities worldwide if vaccine inequity is allowed to persist.

Source: Voice of America

Malawi Trial Shows New Typhoid Vaccine Effective in Children

Malawi plans a nationwide rollout of the newest typhoid vaccine after a two-year study, the first in Africa, found it safe and effective in children as young as 9 months. Previously available vaccines were found not effective in children younger than 2 years and even then only provided short-term protection.

Typhoid is an increasing public health threat in Malawi and across sub-Saharan Africa with an estimated 1.2 million cases and 19,000 deaths each year.

Typhoid is a treatable bacterial infection that has become a serious threat in many low- and middle-income countries.

In Malawi, the study on the efficacy of the Typhoid Conjugate Vaccine or TCV involved about 28,000 children aged between 9 months and 15 years from three townships in the commercial capital, Blantyre.

The University of Maryland School of Medicine’s Center for Vaccine Development and Global Health, the Blantyre Malaria Project, and the Malawi-Liverpool-Wellcome Trust conducted the study.

Professor Melita Gordon, principal investigator for the study at the Malawi-Liverpool Wellcome Trust, says the results, released this week, show an efficacy rate of more than 80% in protecting children against the disease.

“The previous vaccines were only 50% effective, and they were never even tested very well in the very youngest children. They were never even usable in the youngest children. So, the fact that this new conjugate vaccine works in pre-school children, right down to 9 months is a really big deal and important to be able to tackle typhoid across the board in all the children who suffer with it,” she said.

Gordon also said the vaccine efficacy data provides hope that sub-Saharan Africa can be rid of the multidrug-resistant strain of typhoid that arrived from Asia about a decade ago.

“In Malawi, the incidents are something [around] four or five hundred cases per 100,000 per year. Now anything over 200 is considered high incidence, so we are a very high-incidence country. There have been studies in Burkina Faso, in Ghana, in Kenya; we know that many other African countries have an equivalent burden of the disease,” Gordon said.

Dr. Queen Dube, chief of health services in Malawi’s Health Ministry, says rollout should begin soon.

“The exciting news is that we had applied to GAVI that supports us on the vaccination front to add this to the list of vaccines we are administering in the country and GAVI approved our application. And we are looking at introducing this typhoid vaccine and rolling it out next year,” Dube said.

However, some fear the new typhoid vaccine would face hesitancy and resistance from people, as has been the case with COVID-19 vaccines, and which led to the incineration of about 20,000 expired doses in Malawi in May.

But Dube said this won’t happen with typhoid vaccine because COVID-19 was a new disease.

“We have had typhoid for decades and decades, so people know what typhoid is. Nobody will wake up in the morning saying, oh no, typhoid was manufactured in a laboratory. And so, chances that you will end up with misinformation are on the lower side compared with a new disease which swept across the globe, killing so many people brought a lot of fear and a allowed a lot of false theories,” she said.

Still, Dube said Malawi’s government plans to launch a massive sensitization campaign to teach people about the new typhoid vaccine to a reemergence of the myths and misinformation that engulfed the COVID-19 vaccine rollout.

Source: Voice of America

Ex-Algerian President Bouteflika, Ousted Amid Protests, Dies at 84

Former Algerian President Abdelaziz Bouteflika, who fought for independence from France, reconciled his conflict-ravaged nation and was then ousted amid pro-democracy protests in 2019 after two decades in power, has died at age 84.

A statement from the office of current President Abdelmadjid Tebboune, did not provide the cause of death or information about funeral arrangements.

Bouteflika had suffered a stroke in 2013 that badly weakened him. Concerns about his state of health, kept secret from the Algerian public, helped feed public frustration with his 20-year, corruption-tarnished rule. Mass public protests by the Hirak movement led to his departure.

An astute political chameleon, Bouteflika had been known as a wily survivor ever since he fought for independence from colonial ruler France in the 1950s and 1960s.

He stood up to Henry Kissinger as Algeria’s long-serving foreign minister, successfully negotiated with the terrorist known as Carlos the Jackal to free oil ministers taken hostage in a 1975 attack on OPEC headquarters, and helped reconcile Algerian citizens with each other after a decade of civil war between radical Muslim militants and Algeria’s security forces.

“I’m a non-conformist politician. I’m a revolutionary,” Bouteflika told The Associated Press on the eve of his first presidential victory in 1999, after a campaign tarnished by fraud charges that drove his six rivals to pull out of the vote.

Upon taking office, Bouteflika promised “to definitively turn the somber pages of our history to work for a new era.”

Born March 2, 1937, to Algerian parents in the border town of Oujda, Morocco, Bouteflika was among Algeria’s most enduring politicians.

In 1956, Bouteflika entered the National Liberation Army, formed to fight Algeria’s bloody independence war. He commanded the southern Mali front and slipped into France clandestinely.

After the war’s end, Bouteflika became foreign minister at just 25, at a time when Algeria was a model of doctrinaire socialism tethered to the Soviet Union. Its capital, Algiers, was nicknamed “Moscow on the Med.”

He kept that post for 16 years, helping to raise Algeria’s influence and define the country as a leader of the Third World and the Non-Aligned Movements. He was active in the United Nations and presided over the U.N. General Assembly in 1974.

In 1978, he slipped from sight for nearly two decades, spending more than six years in exile to escape corruption charges that were later dropped.

Algeria’s army held the reins of power throughout that time. The National Liberation Army had been transformed into a single party that ruled until 1989, when a multiparty system was introduced.

But as the Islamic Salvation Front party, or FIS, rapidly gained support, the army canceled Algeria’s first multi-party legislative elections in 1992 to thwart a likely victory by the Muslim fundamentalists. An insurgency erupted that left an estimated 200,000 dead over the ensuing years.

Bouteflika took office in 1999, Algeria’s first civilian leader in more than three decades. He managed to bring stability to a country nearly brought to its knees by the violence, unveiling a bold program in 2005 to reconcile the fractured nation by persuading Muslim radicals to lay down their arms.

Bouteflika and the armed forces neutralized Algeria’s insurgency, but then watched it metastasize into a Saharan-wide movement linked to smuggling and kidnapping — and to al-Qaida.

Bouteflika stood with the United States in the fight against terrorism after the Sept. 11, 2001, attacks, particularly on intelligence-sharing and military cooperation. It marked a turnaround from the militantly anti-American, Soviet-armed Algeria of years past when figures like Black Panther leader Eldridge Cleaver took refuge there.

Bouteflika’s powerful political machine had the constitution changed to cancel the presidency’s two-term limit. He was then reelected in 2009 and 2013, amid charges of fraud and a lack of powerful challengers.

His firebrand past dissolved as age and illness took its toll on the once-charismatic figure. Corruption scandals over infrastructure and hydrocarbon projects dogged him for years and tarnished many of his closest associates. His brother, two former prime ministers and other top officials are now in prison over corruption.

Bouteflika balked at the region-wide calls for change embodied by the 2011 Arab Spring revolutions that overthrew three dictators to his east. Bouteflika tamped down unrest through salary and subsidy increases, a vigilant security force and a lack of unity in the country’s opposition. He also failed to restore civic trust or create an economy that could offer the jobs needed for Algeria’s growing youth population despite the nation’s vast oil and gas wealth.

Bouteflika was increasingly absent from view during his third and fourth presidential terms after suffering a stroke. The extent to which Bouteflika was controlled by the army remained unclear. He once told the AP that he turned down the job of president in 1994 because he was unable to accept conditions set by the military.

Algeria’s Hirak protests erupted after he announced plans to run for a fifth term in 2019, and it was the then-army chief who sealed Bouteflika’s fate by siding with the demonstrators. Bouteflika had no choice but to step down.

Despite new elections and some gestures toward the protesters, Algeria’s leadership remains opaque and has recently cracked down on dissent, notably among Berber populations.

The secrecy surrounding Algeria’s leaders is such that it’s unclear whether Bouteflika ever married or had any survivors.

Source: Voice of America

Somalia Blasts Djibouti Over ‘Unlawful Detention’ of National Security Adviser

Somalia’s government has condemned what it calls the unlawful detention of President Mohamed Abdullahi Farmajo’s national security adviser.

Somali government spokesman Abdirashid Hashi in a tweet Friday said Fahad Yasin was detained at Djibouti airport.

Yasin was flying from Turkey to Mogadishu with a stop in Djibouti.

Government spokesman Hashi tweeted such acts will not help to strengthen ties between Somalia and Djibouti.

Djibouti’s Minister of Economy and Finance Ilyas Dawaleh tweeted a response to the communication director’s accusation.

Dawaleh asked him to “refrain from any inappropriate and baseless statements.”

Djibouti’s Foreign Minister Mohamed Yusuf added, “There are fake news released in social media trying to create confusion and drag Djibouti into Somalia internal challenges and crisis. We will continue to stand by our brothers and sisters in Somalia but never interfere in their internal affairs.”

Yasin, who is the former head of Somalia’s National Intelligence and Security Agency, is at the center of a power struggle between Somalia’s president and prime minister.

Prime Minister Mohamed Hussein Roble suspended Yasin over the disappearance of a female cybersecurity spy, who the agency says was killed by al-Shabab militants.

Her family believes Somalia’s spy agency was responsible for her disappearance.

Yasin was due to attend a national security meeting on Saturday to discuss the controversial case.

The case has Farmajo and Roble in a stand-off that threatens the country’s elections and security gains.

Farmajo on Thursday issued a suspension of Roble’s executive powers, which the prime minister promptly rejected.

Source: Voice of America